December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

28.57 -0.73 (-2.49%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
News headline image
Viatris To Pay $264M As EpiPen Antitrust Litigation Settlement: Reuters ↗
Viatris Inc (NASDAQ: VTRS), previously known as Mylan, has agreed to pay $264 million to resolve a class-action lawsuit alleging it engaged in a scheme to delay... 
Via Benzinga
News headline image
Putin on the brink ↗
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott. 
Via Talk Markets
News headline image
Red Ink ↗
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph 
Via Talk Markets
News headline image
A Receding tide ↗
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient. 
Via Talk Markets
News headline image
Why Are Teva Pharmaceutical Shares Trading Higher Today? ↗
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)  
Via Benzinga
News headline image
The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical ↗
Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled. 
Via Investor's Business Daily
News headline image
Earnings Scheduled For February 9, 2022 ↗
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion. 
Via Benzinga
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept... 
Via FinancialNewsMedia
News headline image
World Markets News For Thursday ↗
Ericsson stock lost another 5.27% today in US markets. 
Via Talk Markets
News headline image
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora ↗
According to Coherent Market Insights, the global cannabis extract market is estimated to be valu... 
Via Benzinga
News headline image
Price To Earnings Ratio Insights For Teva Pharmaceutical ↗
  
Via Benzinga
News headline image
Teva, Texas Enter $225M Opioid Settlement Agreement ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a  
Via Benzinga
News headline image
Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment ↗
A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun O... 
Via Benzinga
News headline image
World Markets News For Monday ↗
European markets were down over fear of Ukrainian battles. 
Via Talk Markets
News headline image
Nuclear Winter ↗
Mexico is raising interest rates to 6%, from 5.5%. 
Via Talk Markets
News headline image
Inflation inflating ↗
The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays. 
Via Talk Markets
News headline image
Dampening Exuberance ↗
The bond sell-off halted today but the Fed's plans mean this will resume. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Teva Pharmaceutical: Q4 Earnings Insights ↗
  Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Markets News for Tuesday ↗
Oil stocks are up on huge gains. 
Via Talk Markets
News headline image
Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Weakened Tech Stocks ↗
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks. 
Via Talk Markets
News headline image
World Markets News for Wednesday ↗
Gold and the Euro are up as the greenback loses traction. 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
News headline image
World Markets News for Tuesday ↗
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon. 
Via Talk Markets
News headline image
Research Finds COVID Pandemic Worsened Health Equity Gap
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Drug Troubles ↗
The drug sector has both good news and bad. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 ↗
Upgrades 
Via Benzinga
News headline image
The Best REITs To Buy Right Now Will Pay 8.5% Yield ↗
Stocks had a great 2021, if a tad wild - the S&P 500 finished up nearly 27% for the year. But the performance of real estate investment trusts (REITs) last year flat-out blew stocks out of the water -... 
Via Talk Markets
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.